There were 251 press releases posted in the last 24 hours and 428,917 in the last 365 days.

Xtalks Announces its July 2017 Webinars

/EINPresswire.com/ -- TORONTO, ON--(Marketwired - July 05, 2017) - Upcoming free, educational webinars from Xtalks Life Sciences will feature topics on clinical trials, clinical data, drug development and drug discovery, pharmacovigilance, pharmacology, pharmaceutical manufacturing and logistics, biosimilars and medical device webinars.

Stay on top of current hot topics through free webinars presented by leading experts in pharma and biotech industries et al. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field! Visit www.xtalks.com to check out our upcoming webinars. Or click below to learn more about each webinar:

CLINICAL TRIALS

CLINICAL DATA

DRUG DEVELOPMENT & DRUG DISCOVERY

PHARMACOVIGILANCE

PHARMACOLOGY

PHARMACEUTICAL MANUFACTURING

PHARMACEUTICAL LOGISTICS

BIOSIMILARS

MEDICAL DEVICE

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit: http://xtalks.com

For information about hosting a webinar visit: http://xtalks.com/sponsorship.ashx

Contact:
Vicki Pannu
Tel: +1 (416) 977-6555 ext 284
Email: vpannu@xtalks.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.